Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China food safety efforts

This article was originally published in The Tan Sheet

Executive Summary

China will spend 8.8 bil. yuan ($1.1 bil.) during the next three to five years to strengthen food and drug oversight and infrastructure, China's State Food and Drug Administration Spokeswoman Yan Jiangying said during a press conference in Beijing Aug. 8. Approximately 6.3 bil. yuan ($790 mil.) will be funded by the central government for initiatives in Western and Central China, while the rest will come from local governments in Eastern China, she added. On May 24, SFDA announced the "2007 National Plan of Special Rectification of Food Safety" to improve the safety of food eaten in China and exported food (1"The Tan Sheet" June 4, 2007, p. 12). In other safety news, Yan noted SFDA has released a list of Web sites that may legally sell drugs online, including four retail sites authorized to sell nonprescription drugs to consumers...

You may also be interested in...



USP site in China

U.S. Pharmacopeia's newest international site in Shanghai will enable the organization to work with Chinese regulators and manufacturers to ensure the safety of dietary supplements, pharmaceuticals and food ingredients, USP states in a Sept. 6 release. The opening of the site was celebrated with a ribbon-cutting ceremony Sept. 8, which was attended by USP executives as well as State Food and Drug Administration officials, among others. "USP-China will work closely with SFDA, the Chinese Pharmacopeia Commission, [the National Institute for the control of Pharmaceutical and Biological Products] and other constituencies to help ensure the quality of medicines and food ingredients," USP says. "Our presence will benefit Chinese manufacturers, government agencies and ultimately patients in China, U.S. and the many countries to which China exports," organization adds. SFDA recently announced it was planning to spend 8.8 bil. yuan ($1.1 bil.) over the next three to five years to strengthen food and drug oversight and infrastructure (1"The Tan Sheet" Aug. 27, 2007, In Brief)...

A “Waking Giant” In Food Safety? Experts Discuss China’s Future Of Reform

"It should come as no surprise if China emerges as a leader in food safety reform," United Natural Products Alliance Executive Director Loren Israelsen said

Moment Of Truth For Seven EU Filings; Cytokinetics To Make Its Case For Heart Failure Drug

The CHMP, the European Medicines Agency’s human medicines committee, will this week decide whether a range of new medicines merit being approved.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100835

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel